- Home
- VIVS vs YCBD Comparison
VIVS vs YCBD Comparison
Compare VIVS & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- YCBD
- Stock Information
- Founded
- VIVS 2007
- YCBD 2015
- Country
- VIVS United States
- YCBD United States
- Employees
- VIVS N/A
- YCBD N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- VIVS Health Care
- YCBD Health Care
- Exchange
- VIVS Nasdaq
- YCBD Nasdaq
- Market Cap
- VIVS 8.1M
- YCBD 7.8M
- IPO Year
- VIVS N/A
- YCBD N/A
- Fundamental
- Price
- VIVS $2.25
- YCBD $0.63
- Analyst Decision
- VIVS
- YCBD Strong Buy
- Analyst Count
- VIVS 0
- YCBD 1
- Target Price
- VIVS N/A
- YCBD $2.00
- AVG Volume (30 Days)
- VIVS 1.4M
- YCBD 174.6K
- Earning Date
- VIVS 11-06-2025
- YCBD 12-17-2025
- Dividend Yield
- VIVS N/A
- YCBD N/A
- EPS Growth
- VIVS N/A
- YCBD N/A
- EPS
- VIVS N/A
- YCBD N/A
- Revenue
- VIVS $140,000.00
- YCBD $19,026,064.00
- Revenue This Year
- VIVS $42.38
- YCBD $0.37
- Revenue Next Year
- VIVS $15.42
- YCBD $4.95
- P/E Ratio
- VIVS N/A
- YCBD N/A
- Revenue Growth
- VIVS 35.92
- YCBD N/A
- 52 Week Low
- VIVS $1.41
- YCBD $0.52
- 52 Week High
- VIVS $21.96
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- VIVS 45.97
- YCBD 29.22
- Support Level
- VIVS $2.02
- YCBD $0.76
- Resistance Level
- VIVS $2.36
- YCBD $0.83
- Average True Range (ATR)
- VIVS 0.29
- YCBD 0.07
- MACD
- VIVS 0.01
- YCBD -0.03
- Stochastic Oscillator
- VIVS 23.64
- YCBD 19.87
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.